At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 94 enrolled
Drug / intervention
Toradoldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Toradol to Reduce Ureteroscopic Symptoms Trial
In Brief
A Phase 2 clinical trial evaluating Toradol for Urinary Lithiasis and 3 related conditions. Completed, enrolled 94 participants across 1 site.
Detailed Summary
Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Lithiasis, Kidney Diseases, Kidney Stone, Pain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedApr 2017
Enrollment StartAug 2017
Primary CompletionJun 2020
TodayJul 2026
First PostedApr 12, 2017
Enrollment StartAug 1, 2017
Primary CompletionJun 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.2 years ago
Interventions
Toradoldrug
IV toradol